Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
1 other identifier
observational
295
1 country
1
Brief Summary
Retrospective single center analyses of COVID-19 patients admitted to the ICU between 01/02/2020 and 31/07/2021.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 8, 2021
CompletedFirst Submitted
Initial submission to the registry
December 10, 2021
CompletedFirst Posted
Study publicly available on registry
December 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2022
CompletedDecember 21, 2022
December 1, 2022
1.2 years
December 10, 2021
December 20, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mortality
mortality of patients during their stay at the ICU
through study completion, an average of 1 year
Secondary Outcomes (5)
3 Months Mortality
3 months after admission to ICU
acute kidney injury
through study completion, an average of 1 year
continous renal replacement therapy
through study completion, an average of 1 year
Length of stay in hospital
through study completion, an average of 1 year
Length of stay in ICU
during ICU stay
Other Outcomes (1)
Complications
through study completion, an average of 1 year
Study Arms (1)
COVID-19 patients
COVID-19 patients admitted to the ICU
Interventions
Eligibility Criteria
All adult COVID-19 patients (\>18 years) admitted to the ICU between 01/02/2020 and 31/07/2021 with a laboratory confirmation of COVID-19 infection with a positive result on polymerase chain reaction (PCR) assays of nasopharyngeal swab samples or bronchoalveolar lavage
You may qualify if:
- All adult COVID-19 patients (\>18 years) admitted to the ICU between 01/02/2020 and 31/07/2021 with a laboratory confirmation of COVID-19 infection with a positive result on polymerase chain reaction (PCR) assays of nasopharyngeal swab samples or bronchoalveolar lavage
You may not qualify if:
- All adult patients admitted for other reasons to the ICU (no COVID-19 pneumonia)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jessa Hospitallead
Study Sites (1)
Jessa Hospital
Hasselt, Limburg, 3500, Belgium
Related Publications (2)
Madrid-Valero JJ, Ware J, Allen JM, Boughton CK, Hartnell S, Wilinska ME, Thankamony A, de Beaufort C, Schierloh U, Campbell FM, Sibayan J, Bocchino LE, Kollman C, Hovorka R, Gregory AM, Consortium K. Sleep Quality and Quantity in Caregivers of Children with Type 1 Diabetes Using Closed-Loop Insulin Delivery or a Sensor-Augmented Pump. Pediatr Diabetes. 2023 Jun 13;2023:7937007. doi: 10.1155/2023/7937007. eCollection 2023.
PMID: 40303271DERIVEDStessel B, Bin Saad M, Ullrick L, Geebelen L, Lehaen J, Timmermans PJ, Van Tornout M, Callebaut I, Vandenbrande J, Dubois J. Extracorporeal Membrane Oxygenation to Support COVID-19 Patients: A Propensity-Matched Cohort Study. Crit Care Res Pract. 2023 Jun 12;2023:5101456. doi: 10.1155/2023/5101456. eCollection 2023.
PMID: 37342313DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 10, 2021
First Posted
December 15, 2021
Study Start
September 8, 2021
Primary Completion
November 30, 2022
Study Completion
November 30, 2022
Last Updated
December 21, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share